{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-039747","form_type":"8-K","ticker":null,"cik":"0001845459","company_name":"NKGen Biotech, Inc.","filed_at":"2024-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.965887+00:00","generated_at":"2026-06-04T07:22:13.686600+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NKGen Biotech issues $660k in convertible notes and warrants to two investors","bullets":["Sold $330k principal 12% notes at $300k each (OID $30k) to FirstFire and Meteora, due March 2025.","Each note convertible at $2.00/share; warrants for up to 330k shares each at $2.00.","Total gross proceeds $600k; first 12 months interest ($39,600) guaranteed and earned upfront.","Conversion capped at 4.99% beneficial ownership; Event of Default triggers floor price as low as $0.65.","Notes are unsecured, may convert at Holder's option anytime until maturity; 330 shares reserved per note."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-039747","json":"https://secwatch.observer/filing/0001104659-24-039747.json","markdown":"https://secwatch.observer/filing/0001104659-24-039747.md","text":"https://secwatch.observer/filing/0001104659-24-039747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845459/000110465924039747/0001104659-24-039747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845459/000110465924039747/tm249972d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:22:13.686600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"63d0006f66b5b6731e5a0c88cdb768171f530452","claim":"NKGen Biotech, Inc. incurred convertible notes of $330,000 with Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Captial, LLC at 12% maturing March 26, 2025.","evidence_excerpt":"On March 26, 2024, the Company issued a 12% promissory note (the “ Meteora Note ”) in the principal amount of $330,000, pursuant to a Securities Purchase Agreement (the “ Meteora Purchase Agreement ”), by and among Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Captial, LLC (collectively, “ Meteora ”) and the Company.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845459/000110465924039747/0001104659-24-039747-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$330,000"},{"label":"Counterparty","value":"Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Captial, LLC"},{"label":"Rate","value":"12%"},{"label":"Maturity","value":"March 26, 2025"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"903966346a89b5115b5b948836be4310181d3631","claim":"NKGen Biotech, Inc. incurred convertible notes of $330,000 with FirstFire Global Opportunities Fund, LLC at 12% maturing March 21, 2025.","evidence_excerpt":"On March 21, 2024, NKGen Biotech, Inc. (the “ Company ”) issued a 12% promissory note (the “ FirstFire Note ”) in the principal amount of $330,000, pursuant to a Securities Purchase Agreement (the “ FirstFire Purchase Agreement ”), by and between the Company and FirstFire Global Opportunities Fund, LLC (“ FirstFire ”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845459/000110465924039747/0001104659-24-039747-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$330,000"},{"label":"Counterparty","value":"FirstFire Global Opportunities Fund, LLC"},{"label":"Rate","value":"12%"},{"label":"Maturity","value":"March 21, 2025"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"02f0a8f7dcd11719962de0ee5e828a78fb5e9bd3","claim":"NKGen Biotech, Inc. entered into Meteora Note with Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC valued at $330,000 principal amount, $30,000 original issue discount (effective 2024-03-26).","evidence_excerpt":"On March 26, 2024, the Company issued a 12% promissory note (the “ Meteora Note ”) in the principal amount of $330,000, pursuant to a Securities Purchase Agreement (the “ Meteora Purchase Agreement ”), by and among Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Captial, LLC (collectively, “ Meteora ”) and the Company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845459/000110465924039747/0001104659-24-039747-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC"},{"label":"Value","value":"$330,000 principal amount, $30,000 original issue discount"},{"label":"Effective","value":"2024-03-26"}],"fact_type":"material_agreement"},{"claim_id":"2fd35976a6bd6039b5197638836c5e9dbada2736","claim":"NKGen Biotech, Inc. entered into FirstFire Note with FirstFire Global Opportunities Fund, LLC valued at $330,000 principal amount, $30,000 original issue discount (effective 2024-03-21).","evidence_excerpt":"On March 21, 2024, NKGen Biotech, Inc. (the “ Company ”) issued a 12% promissory note (the “ FirstFire Note ”) in the principal amount of $330,000, pursuant to a Securities Purchase Agreement (the “ FirstFire Purchase Agreement ”), by and between the Company and FirstFire Global Opportunities Fund, LLC (“ FirstFire ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845459/000110465924039747/0001104659-24-039747-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"FirstFire Global Opportunities Fund, LLC"},{"label":"Value","value":"$330,000 principal amount, $30,000 original issue discount"},{"label":"Effective","value":"2024-03-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}